Concepedia

Goli B. Naderi

GB

2

Publications

729

Citations

2

H-Index

2002

Active since

Affiliations

Novartis (United States)(Current)

Goli B. Naderi is an author at Novartis (United States) specializing in molecular pharmacology, medicine, and medicinal chemistry.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryPeptide SciencePharmacotherapyDrug DevelopmentNatural SciencesMedicinal ChemistryMolecular Pharmacology

Publications per year

2002–2003

2

Publications

2

1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties

Edwin B. Villhauer, J. A. Brinkman, Goli B. Naderi et al. · Journal of Medicinal Chemistry · 2003 · 609 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +14

1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(<i>S</i>)-pyrrolidinecarbonitrile: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties

Edwin B. Villhauer, J. A. Brinkman, Goli B. Naderi et al. · Journal of Medicinal Chemistry · 2002 · 120 citations · Full text

Pharmaceutical Science, Peptide Science, Pharmacotherapy +18

Rows per page

1–2 of 2